Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry, v3.5.5, was added to the history, replacing the prior v3.5.4.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page footer revision label changed from v3.5.3 to v3.5.4, indicating a minor version update to the page.SummaryDifference0.0%

- Check36 days agoChange DetectedThe history now includes a new revision entry labeled v3.5.3 and removes the previous v3.5.2, indicating the record has been updated to a newer version.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded revision entry v3.5.2 and removed revision v3.5.0 from the record history.SummaryDifference0.0%

- Check79 days agoChange DetectedAdded revision: v3.5.0 to the history and removed revision: v3.4.3.SummaryDifference0.0%

- Check86 days agoChange Detected- Revision history updated: v3.4.3 added and v3.4.2 removed.SummaryDifference0.0%

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.